Literature DB >> 1747023

Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

F M Benes1, J McSparren, E D Bird, J P SanGiovanni, S L Vincent.   

Abstract

A recent report suggested that neurons in the prefrontal, anterior cingulate, and primary motor cortex of the brains of schizophrenic subjects may be less dense than those in the brains of nonschizophrenic subjects. We have determined whether pyramidal neurons and/or interneurons are preferentially reduced in schizophrenic subjects. Twelve control subjects and 18 schizophrenic subjects were studied in a blind, quantitative analysis of the density of pyramidal cells, interneurons, and glial cells in each of the six layers of the anterior cingulate and prefrontal cortex. The results showed that numbers of small neurons (interneurons) were reduced in most layers of the cingulate cortex in schizophrenic subjects compared with nonschizophrenic subjects, with the differences being greatest in layer II. In the prefrontal area, interneuronal density was also lower in layer II and, to a lesser extent, in layer I in schizophrenic subjects compared with control subjects. In most cases, the differences were similar, although more significant, in schizophrenic subjects who had had superimposed mood disturbances than in schizophrenic subjects who had not had such comorbidity. Numbers of pyramidal neurons generally were not different between control and schizophrenic subjects, except in layer V of the prefrontal area, where schizophrenic subjects showed higher densities of these neurons. Glial numbers did not differ between the control and schizophrenic subjects, suggesting that a neurodegenerative process did not cause the reduced interneuronal density observed. Using multiple regression analysis and analysis of covariance, decreases in the density of layer II interneurons could not be adequately explained by the effects of various confounding variables, such as age, postmortem interval, duration of specimen fixation, or administration of neuroleptic agents.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1747023     DOI: 10.1001/archpsyc.1991.01810350036005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  177 in total

1.  Subnucleus-specific loss of neurons in medial thalamus of schizophrenics.

Authors:  G J Popken; W E Bunney; S G Potkin; E G Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 2.  The neurobiology of autism: new pieces of the puzzle.

Authors:  Maria T Acosta; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2003-03       Impact factor: 5.081

3.  Astrocyte decrease in the subgenual cingulate and callosal genu in schizophrenia.

Authors:  Matthew Roy Williams; Thomas Hampton; Ronald K B Pearce; Steven Richard Hirsch; Olaf Ansorge; Maria Thom; Michael Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06-04       Impact factor: 5.270

Review 4.  Inhibition of the cortex using transcranial magnetic stimulation in psychiatric populations: current and future directions.

Authors:  Natasha Radhu; Lakshmi N Ravindran; Andrea J Levinson; Zafiris J Daskalakis
Journal:  J Psychiatry Neurosci       Date:  2012-11       Impact factor: 6.186

Review 5.  GABAergic interneuron origin of schizophrenia pathophysiology.

Authors:  Kazu Nakazawa; Veronika Zsiros; Zhihong Jiang; Kazuhito Nakao; Stefan Kolata; Shuqin Zhang; Juan E Belforte
Journal:  Neuropharmacology       Date:  2011-01-26       Impact factor: 5.250

Review 6.  Insights and treatment options for psychiatric disorders guided by functional MRI.

Authors:  Tonmoy Sharma
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

Review 7.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

8.  Understanding schizophrenia.

Authors:  L S Pilowsky
Journal:  BMJ       Date:  1992-08-08

9.  Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1.

Authors:  Nevena V Radonjić; Igor Jakovcevski; Vladimir Bumbaširević; Nataša D Petronijević
Journal:  Psychopharmacology (Berl)       Date:  2013-02-05       Impact factor: 4.530

10.  Prefrontal cognitive deficits in mice with altered cerebral cortical GABAergic interneurons.

Authors:  Gregory B Bissonette; Mihyun H Bae; Tejas Suresh; David E Jaffe; Elizabeth M Powell
Journal:  Behav Brain Res       Date:  2013-11-07       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.